Incidence and case fatality of aneurysmal subarachnoid hemorrhage admitted to hospital between 2008 and 2014 in Norway - Scorecard - MDSpire

Incidence and case fatality of aneurysmal subarachnoid hemorrhage admitted to hospital between 2008 and 2014 in Norway

  • By

  • Lise R. Øie

  • Ole Solheim

  • Paulina Majewska

  • Trond Nordseth

  • Tomm B. Müller

  • Sven M. Carlsen

  • Heidi Jensberg

  • Øyvind Salvesen

  • Sasha Gulati

  • June 30, 2020

  • 0 min

Share

Clinical Scorecard: Hospital Admissions for Aneurysmal Subarachnoid Hemorrhage: Incidence and Mortality Rates in Norway from 2008 to 2014

At a Glance

CategoryDetail
ConditionAneurysmal Subarachnoid Hemorrhage (aSAH)
Key MechanismsRupture of intracranial aneurysm causing bleeding into the subarachnoid space; risk influenced by aneurysm size/type, female gender, age, hypertension, smoking, and alcohol abuse
Target PopulationAdults aged 18 years and older, more common between 40-60 years
Care SettingNorwegian public hospitals with free inpatient treatment under the national health care system

Key Highlights

  • aSAH accounts for approximately 5% of all strokes and has high risk of poor outcome or death
  • Incidence rates of aSAH in Norway were studied from 2008 to 2014 using national registries with validated diagnosis codes
  • Modifiable risk factors such as hypertension, smoking, and alcohol abuse remain critical targets for prevention

Guideline-Based Recommendations

Diagnosis

  • Use ICD-10 codes I60.0–I60.7 to identify aneurysmal SAH; exclude non-aneurysmal SAH codes (I60.8–I60.9) for accurate incidence
  • Diagnosis confirmed by treating physicians and validated with a confirmation rate of 95.3%

Management

  • Hospital admission and treatment provided free of charge in public hospitals
  • Management not influenced by insurance policies due to public healthcare system

Monitoring & Follow-up

  • Follow patients from admission date until death or study end to assess case fatality at 30, 90, and 365 days
  • Monitor for hypertension and diabetes mellitus as comorbidities using registry and prescription data

Risks

  • Higher risk of rupture associated with female gender, older age, aneurysm characteristics, hypertension, smoking, and alcohol abuse
  • Modifiable risk factors should be addressed to reduce incidence

Patient & Prescribing Data

Patients hospitalized with aSAH in Norway aged 18 years or older

Use of oral antithrombotic medications recorded as dichotomous variable; prescriptions tracked via national prescription database ensuring complete registration

Clinical Best Practices

  • Utilize national patient and prescription registries for accurate epidemiological surveillance of aSAH
  • Exclude non-aneurysmal SAH cases to improve precision of incidence estimates
  • Address modifiable risk factors such as hypertension and smoking in prevention strategies
  • Ensure timely hospital admission and standardized care in public hospitals
  • Apply Cox proportional hazards modeling to identify predictors of early mortality post-aSAH

References

Original Source(s)

Related Content